This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
CEL-SCI closes $7.2M public offering to advance Multikine immunotherapy development. Proceeds support continued clinical advancement of the candidate. #Biotech #Healthcare
2026-05-25T03:54:39.074Z